EZH2 inhibition promotes ANGPTL4/CREB1 to suppress the progression of ulcerative colitis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

EZH2 inhibition promotes ANGPTL4/CREB1 to suppress the progression of ulcerative colitis

Published:2020-06 Issue: Volume:250 Page:117553
ISSN:0024-3205
Container-title:Life Sciences
language:en
Short-container-title:Life Sciences

Author:

Li Kun,Yang Jing,Lei Xiao-Fei,Li Shuang-Ling,Yang Hong-Li,Xu Chang-Qing,Deng Li

Funder

Key Technology Research and Development Project of Shandong Province

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference39 articles.

1. Ulcerative colitis;Ungaro;Lancet,2017

2. Cytokines in inflammatory bowel disease;Neurath;Nat. Rev. Immunol.,2014

3. Role of epithelial cells in the pathogenesis and treatment of inflammatory bowel disease;Okamoto;J. Gastroenterol.,2016

4. Apoptosis, necrosis and necroptosis: cell death regulation in the intestinal epithelium;Gunther;Gut.,2013

5. Targeting EZH2 in cancer;Kim;Nat. Med.,2016

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transcription suppression of GABARAP mediated by lncRNA XIST-EZH2 interaction triggers caspase-11-dependent inflammatory injury in ulcerative colitis;Immunobiology;2024-05

2. 1‐Naphthaleneacetic Acid Improved the In Vitro Cell Culturing by Inhibiting Apoptosis;Advanced Biology;2024-01-14

3. CREB1 Silencing Protects Against Inflammatory Response in Rats with Deep Vein Thrombosis Through Reducing RPL9 Expression and Blocking NF-κB Signaling;Journal of Cardiovascular Translational Research;2023-10-27

4. The significance of long non-coding RNAs in the pathogenesis, diagnosis and treatment of inflammatory bowel disease;Precision Clinical Medicine;2023-10-25

5. Dual role of ANGPTL4 in inflammation;Inflammation Research;2023-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3